Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction

Immune checkpoint inhibitors have been widely incorporated for cancer treatment in a variety of solid and hematologic malignancies. Multiple clinical trials have demonstrated the efficacy of PD-1/PD-L1 and CTLA-4 axis inhibition in the metastatic and adjuvant settings. Due to the risks of autoimmune...

Descripción completa

Detalles Bibliográficos
Autores principales: Florou, Vaia, Puri, Sonam, Garrido-Laguna, Ignacio, Wilky, Breelyn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Cancer Immunotherapy: Recent Advances and Challenges
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267318/
https://www.ncbi.nlm.nih.gov/pubmed/34277835
http://dx.doi.org/10.21037/atm-20-5207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267318/
https://www.ncbi.nlm.nih.gov/pubmed/34277835
http://dx.doi.org/10.21037/atm-20-5207

Ejemplares similares